Evidence map›Paper›PMID 35154634›Full record

ArticleTherapeutic advances in endocrinology and metabolism2020

Retinopathy and microalbuminuria are common microvascular complications in cystic fibrosis-related diabetes.

Punith Kempegowda, Harbinder Sunsoa, Joht S Chandan, Lauren M Quinn, Prashant M Amrelia, Syed Noman Atta, Sidrah Amir, Yee Suh Teh, Sabba Chaudhry, Anne de Bray and 4 more

Open access · goldAbstract read
In one paragraph

Article in Therapeutic advances in endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. The endocrine complications of cystic fibrosis.Nature reviews. Endocrinology · 2026
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Cystic Fibrosis-Related Diabetes in Poland.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Punith KempegowdaWellcome Trust Clinical Research Fellow, Institute of Metabolism and Systems Research, University of Birmingham, Edgbaston, Birmingham, B15 2TT, UK.ORCID https://orcid.org/0000-0003-0954-6512
Harbinder SunsoaWest Midlands Adult CF Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Joht S ChandanInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Lauren M QuinnUniversity Hospitals of Leicester, Leicester, UK.
Prashant M AmreliaDepartment of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, UK.
Syed Noman AttaDepartment of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, UK.
Sidrah AmirDepartment of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, UK.
Yee Suh TehDepartment of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, UK.
Sabba ChaudhryDepartment of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, UK.
Anne de BrayDepartment of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, UK.
Rifat RashidWest Midlands Adult CF Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Joanna L WhitehouseWest Midlands Adult CF Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Edward F NashWest Midlands Adult CF Centre, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Ateeq SyedDepartment of Diabetes and Endocrinology, University Hospitals Birmingham NHS Foundation Trust, UK.
University Hospitals Birmingham NHS Foundation Trust · GBUniversity Hospitals of Leicester NHS Trust · GBUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsTo study the prevalence of microvascular complications and renal changes associated with cystic fibrosis-related diabetes (CFRD).

methodsThis retrospective cohort study was conducted at the West Midlands Adult Cystic Fibrosis centre, United Kingdom. Data regarding age, sex, microalbuminuria, retinopathy neuropathy, and biochemical results were collected for all people with CFRD who had an annual review from 1 January 2018 to 31 December 2018 at the centre. Descriptive statistics were analysed using STATAv15.1.

resultsA total of 189 patients were included, of which 56.6% were male and median age (interquartile range) was 33 (27-39) years; 79.4% (150/189) had their annual review in 2018. Those with a biochemically impaired renal function numbered 7.2% (13/180) and 22.7% (32/141) had microalbuminuria; 17.2% (10/58) had diabetes related retinopathy. No one in our cohort had diabetic ulcers; however, 10.3% (13/126) had absent foot pulses.

conclusionWe found a higher prevalence of microalbuminuria compared with retinopathy in a large cohort of cystic fibrosis adults. This study demonstrates the need for regular specialist follow-up to facilitate early identification of such complications and a long-term prospective cohort to understand underlying mechanisms.

Indexed as

cystic fibrosisdiabetesmicroalbuminurianephropathyneuropathyretinopathy

Identifiers

PMID35154634
PMCPMC8832295
OpenAlexW3093766800

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.